Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILOXAZINE vs VIMSELTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VILOXAZINE vs VIMSELTINIB: Safety Overview

Metric VILOXAZINE VIMSELTINIB
Total FAERS Reports 853 170
Deaths Reported 9 0
Death Rate 1.1% N/A
Hospitalizations 59 5
Average Patient Age 21.6 yrs 45.6 yrs
% Female Patients 47.2% 55.4%
FDA Approval Date Apr 2, 2021 Feb 14, 2025
Manufacturer Supernus Pharmaceuticals, Inc Deciphera Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription